Marina Jerebtsova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marina Jerebtsova has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Sergei Nekhai
Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA
9 shared publications - Namita Kumari
Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA
5 shared publications Nowah Afangbedji
Center for Sickle Cell Disease, College of Medicine, Howard University, Washington, DC
5 shared publications- Asrar Ahmad
Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA
3 shared publications - Patricio E. Ray
Child Health Research Center, University of Virginia School of Medicine, Charlottesville, USA
3 shared publications - Santosh Lumdas Saraf
Division of Hematology & Oncology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA
3 shared publications
Latest Publications
- Open Access
- 22 July 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (14) , 3644-3657
Chronic kidney disease in adults with sickle cell trait: a systematic review and meta-analysis
Sickle cell trait (SCT) may increase the risk of chronic kidney disease (CKD). We aimed to determine the pooled statistics of the association between SCT and CKD. Studies published up to May 2024 that were available on PubMed, Embase, Global Health Library, and Web of Science were screened. We included studies that reported odds ratios or hazard ratios (HRs) of CKD and/or end-stage renal disease (ESRD) and that compared adults with SCT to those without SCT. The risk of bias was evaluated using the Risk Of Bias In Nonrandomized Studies-of Exposures tool. The pooled SCT prevalence was calculated among patients with CKD/ESRD. A random-effects analysis was performed. Only studies with low or some concerns of bias were included, corresponding to 18 847 participants with SCT and 1 060 818 without SCT. Participants with SCT had higher odds of having an estimated glomerular filtration rate (eGFR) of ≤60 mL/min per 1.73 m2, proteinuria, and eGFR ≤60 mL/min per 1.73 m2 and/or proteinuria. The pooled prevalence of SCT among African American individuals with ESRD was 10%; however, the heterogeneity was very high (I2, 85.6%). There was a higher HR for ESRD in the studies that included both males and females than in the study that included only females, suggesting that males have a higher risk of ESRD. Controversial results were observed for the association of CKD with hypertension and diabetes. SCT increases the risk of developing CKD and ESRD. PROSPERO registration: CRD42021275274.
- 22 July 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (14) , 3644-3657
Open AccessChronic kidney disease in adults with sickle cell trait: a systematic review and meta-analysis
Sickle cell trait (SCT) may increase the risk of chronic kidney disease (CKD). We aimed to determine the pooled statistics of the association between SCT and CKD. Studies published up to May 2024 that were available on PubMed, Embase, Global Health Library, and Web of Science were screened. We included studies that reported odds ratios or hazard ratios (HRs) of CKD and/or end-stage renal disease (ESRD) and that compared adults with SCT to those without SCT. The risk of bias was evaluated using the Risk Of Bias In Nonrandomized Studies-of Exposures tool. The pooled SCT prevalence was calculated among patients with CKD/ESRD. A random-effects analysis was performed. Only studies with low or some concerns of bias were included, corresponding to 18 847 participants with SCT and 1 060 818 without SCT. Participants with SCT had higher odds of having an estimated glomerular filtration rate (eGFR) of ≤60 mL/min per 1.73 m2, proteinuria, and eGFR ≤60 mL/min per 1.73 m2 and/or proteinuria. The pooled prevalence of SCT among African American individuals with ESRD was 10%; however, the heterogeneity was very high (I2, 85.6%). There was a higher HR for ESRD in the studies that included both males and females than in the study that included only females, suggesting that males have a higher risk of ESRD. Controversial results were observed for the association of CKD with hypertension and diabetes. SCT increases the risk of developing CKD and ESRD. PROSPERO registration: CRD42021275274.
- Open Access
- 25 April 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (6) , 108541
Ebola virus nucleoprotein interaction with host protein phosphatase-1 regulates its dimerization and capsid formation
- 25 April 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (6) , 108541
Open AccessEbola virus nucleoprotein interaction with host protein phosphatase-1 regulates its dimerization and capsid formation
- Open Access
- 28 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10806
Induction of Hepcidin Expression in the Renal Cortex of Sickle Cell Disease Mice
In patients with sickle cell disease (SCD), chronic hemolysis and frequent blood transfusions cause iron overload and accumulation in the kidneys. The iron deposition is found in the renal cortex and correlates with the severity of hemolysis. In this study, we observed a significant accumulation of iron in the renal cortex of a mouse model of SCD, and assessed the expression of the proteins involved in maintaining renal iron homeostasis. Despite the intracellular iron accumulation, the levels of the transferrin receptor in the kidneys were increased, but the levels of the iron exporter ferroportin were not altered in SCD mice. Ferroportin is regulated by hepcidin, which binds to it and promotes its degradation. We found reduced serum hepcidin levels but increased renal hepcidin production in SCD mice. Furthermore, we observed significant macrophage infiltration and increased expression of intercellular adhesion molecule 1 in the endothelial cells of the kidneys in SCD mice. These observations correlated with elevated levels of proinflammatory cytokines IL-1β and IL-6, which can potentially stimulate hepcidin expression. Taken together, our results demonstrate that in individuals with SCD, a renal inflammation state induces renal hepcidin production that blocks the upregulation of ferroportin levels, resulting in dysregulation of iron homeostasis in the kidney and iron deposition in the renal cortex.
- 28 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10806
Open AccessInduction of Hepcidin Expression in the Renal Cortex of Sickle Cell Disease Mice
In patients with sickle cell disease (SCD), chronic hemolysis and frequent blood transfusions cause iron overload and accumulation in the kidneys. The iron deposition is found in the renal cortex and correlates with the severity of hemolysis. In this study, we observed a significant accumulation of iron in the renal cortex of a mouse model of SCD, and assessed the expression of the proteins involved in maintaining renal iron homeostasis. Despite the intracellular iron accumulation, the levels of the transferrin receptor in the kidneys were increased, but the levels of the iron exporter ferroportin were not altered in SCD mice. Ferroportin is regulated by hepcidin, which binds to it and promotes its degradation. We found reduced serum hepcidin levels but increased renal hepcidin production in SCD mice. Furthermore, we observed significant macrophage infiltration and increased expression of intercellular adhesion molecule 1 in the endothelial cells of the kidneys in SCD mice. These observations correlated with elevated levels of proinflammatory cytokines IL-1β and IL-6, which can potentially stimulate hepcidin expression. Taken together, our results demonstrate that in individuals with SCD, a renal inflammation state induces renal hepcidin production that blocks the upregulation of ferroportin levels, resulting in dysregulation of iron homeostasis in the kidney and iron deposition in the renal cortex.
- Open Access
- 5 June 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (11) , 2606-2608
Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
Yagahira Castro Sesquen, Santosh L Saraf, Victor R Gordeuk, Sergei Nekhai, Marina Jerebtsova; Use of Multiple Urinary Biomarkers for the Early Detection of Chro
- 5 June 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (11) , 2606-2608
Open AccessUse of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
Yagahira Castro Sesquen, Santosh L Saraf, Victor R Gordeuk, Sergei Nekhai, Marina Jerebtsova; Use of Multiple Urinary Biomarkers for the Early Detection of Chro
- Open Access
- 28 April 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (9) , 1854-1857
Soluble urokinase-type plasminogen activator receptor in sickle cell disease–associated chronic kidney disease
- 28 April 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (9) , 1854-1857
Open AccessSoluble urokinase-type plasminogen activator receptor in sickle cell disease–associated chronic kidney disease
- Open Access
- 21 October 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 1029224
Glomerular filtration rate abnormalities in sickle cell disease
Sickle cell disease (SCD) is a group of inherited blood disorders affecting the β-globin gene, resulting in the polymerization of hemoglobin and subsequent sickling of the red blood cell. Renal disease, the most common complication in SCD, begins in childhood with glomerular hyperfiltration and then progresses into albuminuria, a fast decline of glomerular filtration, and renal failure in adults. This mini-review focuses on glomerular filtration abnormalities and the mechanisms of hyperfiltration, explores genetic modifiers and methods of estimating glomerular filtration rates, and examines novel biomarkers of glomerular filtration in SCD.
- 21 October 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 1029224
Open AccessGlomerular filtration rate abnormalities in sickle cell disease
Sickle cell disease (SCD) is a group of inherited blood disorders affecting the β-globin gene, resulting in the polymerization of hemoglobin and subsequent sickling of the red blood cell. Renal disease, the most common complication in SCD, begins in childhood with glomerular hyperfiltration and then progresses into albuminuria, a fast decline of glomerular filtration, and renal failure in adults. This mini-review focuses on glomerular filtration abnormalities and the mechanisms of hyperfiltration, explores genetic modifiers and methods of estimating glomerular filtration rates, and examines novel biomarkers of glomerular filtration in SCD.
- 10 August 2021
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 52 (7) , 582-587
Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney Disease
Introduction: Chronic kidney disease (CKD) is a prevalent complication of sickle cell anemia (SCA). Hyperfiltration that delayed detection of CKD is common in SCA patients. Identification of novel urinary biomarkers correlating with glomerular filtration rates may help to detect and predict progression of renal disease. Methods: Reanalysis of mass spectra of urinary samples obtained from University of Illinois at Chicago identified kringle domain-containing protein HGFL. Results: HGFL levels correlated with hyperfiltration, were significantly reduced at CKD stage 1 compared to stage 0, negatively correlated with progression of CKD and were suitable for differentiation of stage 1. Better prediction of CKD progression to stage 2 was observed for HGFL-based risk prediction compared to the estimated glomerular filtration rate (eGFR)-based prediction. Results from a Howard University patient cohort supported the utility of HGFL-based test for the differentiation of stage 1 of CKD. Conclusion: Urinary HGFL may contribute additional information beyond eGFR and improve diagnosis of early-stage CKD in SCA patients.
- 10 August 2021
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 52 (7) , 582-587
Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney Disease
Introduction: Chronic kidney disease (CKD) is a prevalent complication of sickle cell anemia (SCA). Hyperfiltration that delayed detection of CKD is common in SCA patients. Identification of novel urinary biomarkers correlating with glomerular filtration rates may help to detect and predict progression of renal disease. Methods: Reanalysis of mass spectra of urinary samples obtained from University of Illinois at Chicago identified kringle domain-containing protein HGFL. Results: HGFL levels correlated with hyperfiltration, were significantly reduced at CKD stage 1 compared to stage 0, negatively correlated with progression of CKD and were suitable for differentiation of stage 1. Better prediction of CKD progression to stage 2 was observed for HGFL-based risk prediction compared to the estimated glomerular filtration rate (eGFR)-based prediction. Results from a Howard University patient cohort supported the utility of HGFL-based test for the differentiation of stage 1 of CKD. Conclusion: Urinary HGFL may contribute additional information beyond eGFR and improve diagnosis of early-stage CKD in SCA patients.
- Open Access
- 5 November 2020
- Published by American Society of Hematology in Blood
- Vol. 136 (Supplement) , 30
Use of Multiple Urinary Biomarkers for Early Detection of Chronic Kidney Disease in Sickle Cell Anemia Patients
BACKGROUND: More than 60% of sickle cell anemia (SCA) adults develop chronic kidney disease (CKD). Identification of early stages of CKD in SCA patients at high
- 5 November 2020
- Published by American Society of Hematology in Blood
- Vol. 136 (Supplement) , 30
Open AccessUse of Multiple Urinary Biomarkers for Early Detection of Chronic Kidney Disease in Sickle Cell Anemia Patients
BACKGROUND: More than 60% of sickle cell anemia (SCA) adults develop chronic kidney disease (CKD). Identification of early stages of CKD in SCA patients at high
- Open Access
- 5 May 2020
- Published by Wiley in British Journal of Haematology
- Vol. 190 (1) , e45-e48
Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease
- 5 May 2020
- Published by Wiley in British Journal of Haematology
- Vol. 190 (1) , e45-e48
Open AccessAssociation between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease
- Open Access
Oxygen Levels Affect Macrophage HIV-1 Gene Expression and Delay Resolution of Inflammation in HIV-Tg Mice
While antiretroviral therapy increases the longevity of people living with HIV (PLWH), about 30% of this population suffers from three or more concurrent comorbidities, whose mechanisms are not well understood. Chronic activation and dysfunction of the immune system could be one potential cause of these comorbidities. We recently demonstrated reduced macrophage infiltration and delayed resolution of inflammation in the lungs of HIV-transgenic mice. Additionally, trans-endothelial migration of HIV-positive macrophages was reduced in vitro. Here, we analyze macrophages’ response to LPS challenge in the kidney and peritoneum of HIV-Tg mice. In contrast to the lung infiltration, renal and peritoneal macrophage infiltrations were similar in WT and HIV-Tg mice. Higher levels of HIV-1 gene expression were detected in lung macrophages compared to peritoneal macrophages. In peritoneal macrophages, HIV-1 gene expression was increased when they were cultured at 21% O2 compared to 5% O2, inversely correlating with reduced trans-endothelial migration at higher oxygen levels in vitro. The resolution of macrophage infiltration was reduced in both the lung and the peritoneal cavity of HIV-Tg mice. Taken together, our study described the organ-specific alteration of macrophage dynamics in HIV-Tg mice. The delayed resolution of macrophage infiltration might constitute a risk factor for the development of multiple comorbidities in PLWH.
Open AccessOxygen Levels Affect Macrophage HIV-1 Gene Expression and Delay Resolution of Inflammation in HIV-Tg Mice
While antiretroviral therapy increases the longevity of people living with HIV (PLWH), about 30% of this population suffers from three or more concurrent comorbidities, whose mechanisms are not well understood. Chronic activation and dysfunction of the immune system could be one potential cause of these comorbidities. We recently demonstrated reduced macrophage infiltration and delayed resolution of inflammation in the lungs of HIV-transgenic mice. Additionally, trans-endothelial migration of HIV-positive macrophages was reduced in vitro. Here, we analyze macrophages’ response to LPS challenge in the kidney and peritoneum of HIV-Tg mice. In contrast to the lung infiltration, renal and peritoneal macrophage infiltrations were similar in WT and HIV-Tg mice. Higher levels of HIV-1 gene expression were detected in lung macrophages compared to peritoneal macrophages. In peritoneal macrophages, HIV-1 gene expression was increased when they were cultured at 21% O2 compared to 5% O2, inversely correlating with reduced trans-endothelial migration at higher oxygen levels in vitro. The resolution of macrophage infiltration was reduced in both the lung and the peritoneal cavity of HIV-Tg mice. Taken together, our study described the organ-specific alteration of macrophage dynamics in HIV-Tg mice. The delayed resolution of macrophage infiltration might constitute a risk factor for the development of multiple comorbidities in PLWH.